218 related articles for article (PubMed ID: 29361270)
1. Update on SAMS: Statin-associated muscle symptoms.
Stock JK
Atherosclerosis; 2018 Feb; 269():260-261. PubMed ID: 29361270
[No Abstract] [Full Text] [Related]
2. SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population.
Hubáček JA; Dlouhá D; Adámková V; Zlatohlavek L; Viklický O; Hrubá P; Češka R; Vrablík M
Med Sci Monit; 2015 May; 21():1454-9. PubMed ID: 25992810
[TBL] [Abstract][Full Text] [Related]
3. Statin Intolerance From a Clinician's Perspective.
Whayne TF
Angiology; 2016 Mar; 67(3):205-7. PubMed ID: 26019266
[No Abstract] [Full Text] [Related]
4. Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects.
Peersen K; Munkhaugen J; Sverre E; Kristiansen O; Fagerland M; Vethe NT; Perk J; Husebye E; Dammen T
BMC Cardiovasc Disord; 2021 Dec; 21(1):596. PubMed ID: 34915854
[TBL] [Abstract][Full Text] [Related]
5. Association of SLCO1B1 c.521T>C (rs4149056) with discontinuation of atorvastatin due to statin-associated muscle symptoms.
Linskey DW; English JD; Perry DA; Ochs-Balcom HM; Ma C; Isackson PJ; Vladutiu GD; Luzum JA
Pharmacogenet Genomics; 2020 Dec; 30(9):208-211. PubMed ID: 32453264
[TBL] [Abstract][Full Text] [Related]
6. Muscle and statins: from toxicity to the nocebo effect.
Pedro-Botet J; Climent E; Benaiges D
Expert Opin Drug Saf; 2019 Jul; 18(7):573-579. PubMed ID: 31070941
[TBL] [Abstract][Full Text] [Related]
7. Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study.
Casula M; Gazzotti M; Bonaiti F; OImastroni E; Arca M; Averna M; Zambon A; Catapano AL;
J Intern Med; 2021 Jul; 290(1):116-128. PubMed ID: 33259671
[TBL] [Abstract][Full Text] [Related]
8. Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.
Brunham LR; Baker S; Mammen A; Mancini GBJ; Rosenson RS
Cardiovasc Res; 2018 Jul; 114(8):1073-1081. PubMed ID: 29878063
[TBL] [Abstract][Full Text] [Related]
9. Statin-associated muscle symptoms in coronary patients: design of a randomized study.
Munkhaugen J; Vethe NT; Fagerland MW; Dammen T; Perk J; Gjertsen E; Otterstad JE; Gullestad L; Bergan S; Husebye E
Scand Cardiovasc J; 2019 Jun; 53(3):162-168. PubMed ID: 31030568
[No Abstract] [Full Text] [Related]
10. Statin Toxicity.
Ward NC; Watts GF; Eckel RH
Circ Res; 2019 Jan; 124(2):328-350. PubMed ID: 30653440
[TBL] [Abstract][Full Text] [Related]
11. Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.
Banach M; Rizzo M; Toth PP; Farnier M; Davidson MH; Al-Rasadi K; Aronow WS; Athyros V; Djuric DM; Ezhov MV; Greenfield RS; Hovingh GK; Kostner K; Serban C; Lighezan D; Fras Z; Moriarty PM; Muntner P; Goudev A; Ceska R; Nicholls SJ; Broncel M; Nikolic D; Pella D; Puri R; Rysz J; Wong ND; Bajnok L; Jones SR; Ray KK; Mikhailidis DP
Expert Opin Drug Saf; 2015 Jun; 14(6):935-55. PubMed ID: 25907232
[TBL] [Abstract][Full Text] [Related]
12. Statin Intolerance.
Brown AS; Watson KE
Rev Cardiovasc Med; 2018; 19(S1):S9-S19. PubMed ID: 30207553
[TBL] [Abstract][Full Text] [Related]
13. Statin-associated muscle symptoms EAS Consensus Panel paper focuses on this neglected patient group.
Stock J
Atherosclerosis; 2015 Sep; 242(1):346-50. PubMed ID: 26253793
[No Abstract] [Full Text] [Related]
14. Overcoming Challenges With Statin Therapy.
Spence JD; Dresser GK
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26819251
[No Abstract] [Full Text] [Related]
15. Dyslipidaemia: Statin-associated muscle symptoms - really all in the mind?
Stoekenbroek RM; Kastelein JJP
Nat Rev Cardiol; 2017 Aug; 14(8):445-446. PubMed ID: 28631752
[No Abstract] [Full Text] [Related]
16. New insights into managing symptoms during statin therapy.
Robinson JG
Prog Cardiovasc Dis; 2019; 62(5):390-394. PubMed ID: 31669768
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.
Brunham LR; Lansberg PJ; Zhang L; Miao F; Carter C; Hovingh GK; Visscher H; Jukema JW; Stalenhoef AF; Ross CJ; Carleton BC; Kastelein JJ; Hayden MR
Pharmacogenomics J; 2012 Jun; 12(3):233-7. PubMed ID: 21243006
[TBL] [Abstract][Full Text] [Related]
18. Statin-associated muscle symptoms: position paper from the Luso-Latin American Consortium.
Sposito AC; Faria Neto JR; Carvalho LS; Lorenzatti A; Cafferata A; Elikir G; Esteban E; Morales Villegas EC; Bodanese LC; Alonso R; Ruiz AJ; Rocha VZ; Faludi AA; Xavier HT; Coelho OR; Assad MH; Izar MC; Santos RD; Fonseca FA; Mello E Silva A; Silva PM; Bertolami MC;
Curr Med Res Opin; 2017 Feb; 33(2):239-251. PubMed ID: 27776432
[TBL] [Abstract][Full Text] [Related]
19. Towards a More Personalized Treatment of Dyslipidemias to Prevent Cardiovascular Disease.
Hoffmann MM
Curr Cardiol Rep; 2018 May; 20(7):56. PubMed ID: 29802474
[TBL] [Abstract][Full Text] [Related]
20. Statin-Associated Muscle Disease: Advances in Diagnosis and Management.
Taylor BA; Thompson PD
Neurotherapeutics; 2018 Oct; 15(4):1006-1017. PubMed ID: 30251222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]